Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.

Source:http://linkedlifedata.com/resource/pubmed/id/8918496

Download in:

View as

General Info

PMID
8918496